Results 211 to 220 of about 348,919 (331)

Predictive model for low-molecular-weight heparin ineffectiveness in pregnant and postpartum women with intracranial venous sinus thrombosis: a multicenter study. [PDF]

Am J Transl Res
Ye X, Zhang X, Yu L, Hong X, Wang F, Wang L.   +5 more
europepmc   +1 more source

Cardiac disease in systemic sclerosis: Integrating pathobiology with clinical management

Rheumatology &Autoimmunity, EarlyView.
Abstract Systemic sclerosis (SSc) is a complex autoimmune disorder in which cardiovascular involvement remains a major determinant of morbidity and mortality. Cardiac injury in SSc results from the interplay of microvascular dysfunction, immune‐mediated inflammation, and progressive interstitial and replacement fibrosis, leading to myocardial disease ...
Henry Sutanto, Betty Rachma, Yuliasih
wiley   +1 more source

Low-molecular-weight heparin vs aspirin postpartum (LEAP): a single-center pilot randomized control trial. [PDF]

Blood Vessel Thromb Hemost
Vlachodimitropoulou E, Malinowski K, Kaplovitch E, Carrier M, Shehata N.   +4 more
europepmc   +1 more source

Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

Stroke, 1999
M. BruijndeS.F.T., J. Stam, H. Büller, A. Lensing, M. Vermeulen   +4 more
semanticscholar   +1 more source

Scale‐Specific Viscoelastic Characterization of Hydrogels: Integrated AFM and Finite Element Modeling

Small, EarlyView.
An integrated multiscale approach reveals distinct viscoelastic responses of hydrogels across length scales. Combining AFM‐based nanoindentation, finite element modeling, and a novel analytical framework, this study enables accurate, scale‐specific mechanical characterization to guide the design of advanced biomaterials. Abstract Viscoelastic hydrogels
Nicole Fertala, Klemens Uhlmann, Evgeny Grigoryev, Prannoy Seth, Jens Friedrichs, Julian Thiele, Carsten Werner, Daniel Balzani   +7 more
wiley   +1 more source

Establishment of a bleeding risk model for low-molecular-weight heparin in cancer-associated venous thromboembolism: a single-center retrospective study. [PDF]

Front Pharmacol
Zhang Z, Zhou H, Ren C, Liao L.
europepmc   +1 more source

Reprogramming Immunogenicity of Iron Oxide Nanoparticles through Sulfated Glycan Presentation

Small, EarlyView.
This study presents a comparative analysis of heparin (HP)‐ and dextran sulfate (DS)‐coated superparamagnetic iron oxide nanoparticles (SPIONs) as a tunable immunomodulatory platform where surface chemistry dictates therapeutic function. DS‐SPIONs are preferentially internalized by myeloid cells, reprogramming them into a pro‐healing M2 phenotype ...
Negin Pournoori, Heela Sarlus, Dick J. Sjöström, Rohith Pavan Parvathaneni, Oommen P. Varghese, Vesa P. Hytönen, Robert A. Harris, Per H. Nilsson, Oommen P. Oommen   +8 more
wiley   +1 more source

Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case-Control Study. [PDF]

Medicina (Kaunas)
Maglic D, Mandic-Markovic V, Mikovic Z, Maglic R, Anicic R, Mandic M.   +5 more
europepmc   +1 more source

Ligand‐Driven Optimization of Iron Oxide Nanoprobes for In Vivo MRI Enhancement at Ultra‐High Field

Small, EarlyView.
Ligand‐tailored iron oxide nanoparticles reveal how surface chemistry controls T2 relaxivity and in vivo performance in ultra‐high‐field MRI. Systematic variation of hydrophilicity and charge across five coatings modulated r2 by up to 333 mm−1 s−1, with chemical properties, rather than shell thickness, dictating magnetic dephasing and enabling reliable
Pelayo García‐Acevedo, María Luz Alonso‐Alonso, Sara Ortega‐Espina, Manuel Bañobre‐López, Yolanda Piñeiro, Ramón Iglesias‐Rey, José Rivas   +6 more
wiley   +1 more source

Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy. [PDF]

BMC Gastroenterol
Zhang X, Ai Z.
europepmc   +1 more source